Bicocca Open Archive

Logo unimib boa
CAROZZI, VALENTINA ALDA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 11.092
EU - Europa 6.662
AS - Asia 4.339
SA - Sud America 198
OC - Oceania 32
AF - Africa 28
Continente sconosciuto - Info sul continente non disponibili 21
Totale 22.372
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 10.875
SG - Singapore 1.677
CN - Cina 1.431
IT - Italia 1.210
DE - Germania 1.141
RU - Federazione Russa 1.050
SE - Svezia 904
IE - Irlanda 823
UA - Ucraina 607
HK - Hong Kong 543
GB - Regno Unito 309
CA - Canada 206
VN - Vietnam 177
BR - Brasile 167
FI - Finlandia 156
AT - Austria 138
ID - Indonesia 126
FR - Francia 94
IN - India 82
JP - Giappone 78
DK - Danimarca 66
NL - Olanda 56
TR - Turchia 56
KR - Corea 47
BE - Belgio 36
IR - Iran 29
MY - Malesia 22
EU - Europa 19
AU - Australia 18
NZ - Nuova Zelanda 14
PL - Polonia 13
ES - Italia 11
EG - Egitto 10
MX - Messico 10
TW - Taiwan 9
ZA - Sudafrica 9
PK - Pakistan 8
AR - Argentina 7
IQ - Iraq 7
SA - Arabia Saudita 7
AE - Emirati Arabi Uniti 6
BD - Bangladesh 6
CH - Svizzera 6
EC - Ecuador 6
PH - Filippine 6
RS - Serbia 6
HU - Ungheria 5
UZ - Uzbekistan 5
CL - Cile 4
HR - Croazia 4
LV - Lettonia 4
PY - Paraguay 4
RO - Romania 4
CO - Colombia 3
MA - Marocco 3
MD - Moldavia 3
NO - Norvegia 3
SK - Slovacchia (Repubblica Slovacca) 3
VE - Venezuela 3
A1 - Anonimo 2
AF - Afghanistan, Repubblica islamica di 2
AL - Albania 2
BG - Bulgaria 2
BH - Bahrain 2
BO - Bolivia 2
CZ - Repubblica Ceca 2
IL - Israele 2
JO - Giordania 2
KG - Kirghizistan 2
LB - Libano 2
NG - Nigeria 2
OM - Oman 2
PE - Perù 2
PT - Portogallo 2
SC - Seychelles 2
AO - Angola 1
BN - Brunei Darussalam 1
EE - Estonia 1
GE - Georgia 1
GR - Grecia 1
JM - Giamaica 1
TH - Thailandia 1
TN - Tunisia 1
Totale 22.372
Salva come PNG Salva come JPEG
Città #
Ann Arbor 2.213
Singapore 1.073
Woodbridge 900
Dublin 793
Chandler 741
Houston 653
Jacksonville 619
Frankfurt am Main 618
Fairfield 534
Hong Kong 522
Dearborn 505
Milan 487
Wilmington 485
Ashburn 440
Santa Clara 337
Hangzhou 332
New York 324
Princeton 304
Seattle 219
Nanjing 199
Cambridge 165
Boardman 144
Shanghai 138
Vienna 125
Jakarta 117
Beijing 109
Lachine 102
Altamura 92
Dong Ket 89
Lawrence 82
Guangzhou 76
Nanchang 72
Shenyang 62
Council Bluffs 55
Andover 51
Toronto 46
Nuremberg 45
Helsinki 42
Los Angeles 42
Carate Brianza 40
Grafing 37
Moscow 37
Jiaxing 35
Ottawa 34
Rome 34
Tianjin 34
Changsha 33
Chicago 33
Fremont 33
Jinan 33
San Diego 33
Hebei 31
Brussels 28
Falls Church 28
Nürnberg 28
London 26
Melzo 26
Pune 26
Zhengzhou 26
Kunming 24
Mountain View 22
Ningbo 20
Shangdi 20
Dallas 19
Tokyo 18
Codroipo 17
Bergamo 16
Norwalk 16
Phoenix 16
São Paulo 16
Leawood 14
Taizhou 14
Washington 14
Edmonton 13
Hefei 13
Pasir Mas 12
Shinjuku 12
Huizen 11
Kiev 11
Lissone 11
Paris 11
San Mateo 11
Tehran 11
Florence 10
Fuzhou 10
Rio de Janeiro 10
Sesto San Giovanni 10
Sacramento 9
Bologna 8
Changchun 8
Lappeenranta 8
Seoul 8
Trieste 8
Auburn Hills 7
Detroit 7
Düsseldorf 7
Haikou 7
Philadelphia 7
Redmond 7
Romola 7
Totale 15.087
Salva come PNG Salva come JPEG
Nome #
Multimodal assessment of painful peripheral neuropathy induced by chronic oxaliplatin-based chemotherapy in mice 423
Peripheral neuropathy induced by microtubule-targeted chemotherapies: Insights into acute injury and long-term recovery 337
Therapeutic potential of Mesenchymal Stem Cells for the treatment of diabetic peripheral neuropathy 330
High-dose intravenous immunoglobulins reduce nerve macrophage infiltration and the severity of bortezomib-induced peripheral neurotoxicity in rats 313
Global transcriptomic profile of dorsal root ganglion and physiological correlates of cisplatin-induced peripheral neuropathy 311
Age-related changes in the function and structure of the peripheral sensory pathway in mice 308
Susceptibility of different mouse strains to oxaliplatin peripheral neurotoxicity: Phenotypic and genotypic insights 305
Anti-tumor efficacy assessment of the sigma receptor pan modulator RC-106. A promising therapeutic tool for pancreatic cancer 264
Chemotherapy-induced peripheral neurotoxicity in immune-deficient mice: New useful ready-to-use animal models 253
Role of Organic Transporters 1 and 2 in Cisplatin mediated neurotoxicity 251
Neuropathic pain is reduced in acid sphingomyelinase deficient mice. 239
Neurofilament light chain: a specific serum biomarker of axonal damage severity in rat models of Chemotherapy-Induced Peripheral Neurotoxicity 239
Calmangafodipir reduces sensory alterations and prevents intraepidermal nerve fibers loss in a mouse model of oxaliplatin induced peripheral neurotoxicity 230
Molsidomine reduces the severity of Vincristine-induced peripheral neurotoxicity in rats 218
Neutrophil depletion affects Dark Agouti Experimental Autoimmune Encephalomyelitis 213
Bortezomib-induced painful peripheral neuropathy: an electrophysiological, behavioral, morphological and mechanistic study in the mouse 209
Neurofilament light chain as disease biomarker in a rodent model of chemotherapy induced peripheral neuropathy 207
The relevance of multimodal assessment in experimental oxaliplatin-induced peripheral neurotoxicity 206
Bortezomib-induced painful neuropathy in rats: a behavioral, neurophysiological and pathological study in rats 196
CR4056, a new analgesic I2 ligand, is highly effective against bortezomib-induced painful neuropathy in rats 191
Exposure-response relationship of the synthetic epothilone sagopilone in a peripheral neurotoxicity rat model 189
Therapeutic Administration of Mesenchymal Stem Cells Abrogates the Relapse Phase in Chronic Relapsing-Remitting EAE 189
Blood molecular biomarkers for chemotherapy-induced peripheral neuropathy: From preclinical models to clinical practice 187
Expression, distribution and glutamate uptake activity of high affinity-excitatory aminoacid transporters in in vitro cultures of embryonic rat dorsal root ganglia 184
Islet transplantation and insulin administration relieve long-term complications and rescue the residual endogenous pancreatic β cells 182
Molsidomide provides neuroprotection against vincristine-induced peripheral neurotoxicity 179
Givinostat-Liposomes: Anti-Tumor Effect on 2D and 3D Glioblastoma Models and Pharmacokinetics 179
In vivo comparative study of the cytotoxicity of a liposomal formulation of cisplatin (lipoplatin™) 178
The ventral caudal nerve: a physiologic-morphometric study in three different rat strains 177
Bortezomib-Induced Peripheral Neurotoxicity: a Preclinical Model to Study Neuropathic Pain in Rat 176
Platinum-Taxane combination chemotherapy: assessment of electrophysiologic pathologic and morphometric fetures in chronic wistar rat models 172
Paclitaxel: Chemotherapy and Neurotoxicity – The Two sides of the Coin 171
Platinum-taxane combination chemotherapy: General and peripheral neurotoxicity of their combined administration in the rat 170
Effect of the chronic combined administration of cisplatin and paclitaxel in a rat model of peripheral neurotoxicity 170
Cr4056: a novel potent anti-nociceptive agent for several animal models of neuropathic pain 166
Continuous Buprenorphine Delivery Effect in Streptozotocine-Induced Painful Diabetic Neuropathy in Rats 165
Neurophysiological and neuropathological characterization of new murine models of chemotherapy-induced chronic peripheral neuropathies 164
Animal Models for the Study of Human Central and Peripheral Nervous System Diseases 164
Reply to a comment paper on the published paper by canta, a. Et al: “calmangafodipir reduces sensory alterations and prevents intraepidermal nerve fibers loss in a mouse model of oxaliplatin induced peripheral neurotoxicity”—antioxidants 2020, 9, 594 164
Lipoplatin tm: a less neurotoxic formulation of cisplatin 163
Platinum-taxane combination chemotherapy: Description of the first study to assess the general and peripheral neurotoxicity of their combined administration in the rat 162
Antibody Against Tumor Necrosis Factor-α Reduces Bortezomib-induced Allodynia in a Rat Model 159
Focus on the role of Glutamate in the pathology of the peripheral nervous system 156
EVALUATION OF THE EFFICACY OF PERIPHAGEN NEUROTROPHIN-3 EXPRESSING VECTOR FOR OXALIPLATIN INDUCED PERIPHERAL NEUROPATHY. 156
Pathogenesis of platinum-induced peripheral neurotoxicity: Insights from preclinical studies 156
Bortezomib-induced peripheral neurotoxicity in human multiple myeloma-bearing mice 154
Transplanted pancreatic islets survive and reverse type I diabetic neuropathy 154
Lack of sterol regulatory element binding factor-1c imposes glial fatty acid utilization leading to peripheral neuropathy 154
The Role of Oxidative Stress and Anti-Oxidant Treatment in Platinum-Induced Peripheral Neurotoxicity 153
Valproate protective effects on cisplatin-induced peripheral neuropathy: An in vitro and in vivo study 151
Docetaxel-induced peripheral neuropathy: Protective effects of dihydroprogesterone and progesterone in an experimental model 151
Ethoxyquin is effective in preventing cisplatin-induced painful peripheral neuropathy in rats 150
The role of the complete Freund’s adjuvant and neutrophils in actively induced Lewis rat EAE 147
Oxaliplatin induces pH acidification in dorsal root ganglia neurons 147
Morpho-Functional Characterisation of the Rat Ventral Caudal Nerve in a Model of Axonal Peripheral Neuropathy 146
Expression and distribution of 'high affinity' glutamate transporters GLT1, GLAST, EAAC1 and of GCPII in the rat peripheral nervous system 146
Intravenous Immunoglobulin Preparation Attenuates Pain Behaviors in a Wistar Rat Model of Bortezomib-Induced Peripheral Neuropathy 146
ERIBULIN, PACLITAXEL, IXABEPILONE AND VINORELBINE-INDUCED PERIPHERAL NEUROPATHY IN MICE: INSIGHTS IN LONG-TERM RECOVERY 145
Preventive treatment with anti-rat neutrophil serum affects the relapsing phase in Dark Agouti EAE rats 144
The role of glutamate in diabetic and in chemotherapy induced peripheral neuropathies and its regulation by glutamate carboxypeptidase II. 143
Multimodal experimental approach to the study of human neurological diseases 143
Ivig Effect In A Wistar Rat Model Of Bortezomib-Induced Peripheral Neuropathy 143
Evaluation of tubulin polymerization and chronic inhibition of proteasome as citotoxicity mechanisms in bortezomib-induced peripheral neuropathy 142
Effect of preventive and therapeutic treatment of ghrelin agonist HM01 on the peripheral neurotoxicity induced by bortezomib in wistar rats. 142
MSCs effect on Dark Agouti rats affected by chronic EAE 141
Neutrophil depletion during sensitization phase affects the chronic phase of Experimental Autoimmune Encephalomyelitis 141
A Possible role of OCT2 gene in the development of peripheral neurotoxicity induced by cisplatin 141
Regression of diabetic complications by islet transplantation in the rat 140
Co-trasplantation of Pancreatic Islets with Mesenchymal Stem Cells promotes the functional recovery of diabetic neuropathy in vivo 140
Characterization of bortezomib-induced peripheral neuropathy in an immune-suppressed murine model 139
Long-term recovery from chemotherapy-induced neuropathy following paclitaxel, ixabepilone, eribulin and vinorelbine in mice 139
ANALGELSIC EFFECT OF BUPRENORPHINE IN AN EXPERIMENTAL MODEL OF PAINFUL DIABETIC PERIPHERAL NEUROPATHY 138
Human Immunoglobulins ameliorate pain in rats with bortezomib-induced peripheral neuropathy 138
Bortezomib treatment produces nocifensive behavior and changes in the expression of TRPV1, CGRP, and substance P in the rat DRG, spinal cord, and sciatic nerve 137
Ethoxyquin provides neuroprotection against cisplatin-induced neurotoxicity 137
Chemotherapy-induced peripheral neuropathy: What do we know about mechanisms? 137
BORTEZOMIB-INDUCED PERIPHERAL NEUROPATHY: STUDY OF PROTEASOME INHIBITION AND MICROTUBULE STABILIZATION MECHANISMS IN RAT MODEL 136
Bortezomib-induced neuropathic pain: evaluation of antinociceptive effect of a new analgesic compound 135
The severity of oxaliplatin neurotoxicity is related to differential expression of a solute transporter in mice 135
Correlation between organic cation transporter expression in rat dorsal root ganglia neurons and cisplatin-induced peripheral neurotoxicity 133
Imunohystochemical characterization of the distribution of glutamate receptors, “high affinity” membrane bound glutamate transporters and of Glutamate Carboxipeptidase II (GCPII) in in vitro cultures of embryonic dorsal root ganglia. 133
Morphofunctional characterisation of axonal damage in different rat models of chemotherapy-induced peripheral neurotoxicity: the role of nerve excitability testing 132
Effect of proteasome inhibition on the central and peripheral nervous system 132
electrophysiological, behavioural and morphological characterization of oxaliplatin-induced painful peripheral neuropathy in mice 131
Neuroprotective effects of a ligand of translocator protein-18 kDa (Ro5-4864) in experimental diabetic neuropathy 130
Sodium-Calcium Exchanger 2: A Pivotal Role in Oxaliplatin Induced Peripheral Neurotoxicity and Axonal Damage? 129
Oxaliplatin Neurotoxicity is related to SLC4A1 Expression in BALB/c Mice Dorsal Root Ganglia 129
Blood neurofilament light chains as a potential damage marker in chemotherapy-induce peripheral neuropathy rodent models 129
Comparison of neuropathy-inducing effects of eribulin mesylate, paclitaxel, and ixabepilone in mice 127
CISPLATIN, EPOTHILONE B AND BORTEZOMIB-INDUCED PERIPHERAL NEUROPATHIES: A NEUROPHYSIOLOGICAL STUDY IN THE MOUSE. 126
Oxaliplatin-Induced Peripheral Neurotoxicity: Morphological Characterization In Different Mouse Strains 126
Paclitaxel, but Not Cisplatin, Affects Satellite Glial Cells in Dorsal Root Ganglia of Rats with Chemotherapy-Induced Peripheral Neurotoxicity 125
Organic cation transporters and cisplatin-induced peripheral neurotoxicity in dorsal root ganglia neurons 123
Characterization of the neurotoxicity and antineoplastic activity of bortezomib in a new myeloma-bearing murine model. 122
Glutamate Carboxypeptidase II inhibition in several rat models of chemotherapy-induced peripheral neurotoxicity 121
Functional recovery with syngeneically transplanted microcapsulated pancreatic islets in streptozotocin-induced diabetic rats. 119
Glutamate Carboxypeptidase II (GCPII, NAALADASE) inhibition protects against Cisplatin-induced peripheral neurotoxicity in a rat model. 119
Characterization of Glutamate Transporters in Peripheral Nervous System. 118
Expression, distribution and glutamate uptake activity of excitatory aminoacid transporters in in vitro cultures of embryonic rat dorsal root ganglia 118
Glutamate carboxypeptidase inhibition reduces the severity of chemotherapy-induced peripheral neurotoxicity in rat 117
Totale 17.035
Salva come PNG Salva come JPEG
Categoria #
all - tutte 85.200
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 85.200
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020509 0 0 0 0 0 0 0 0 0 252 217 40
2020/20212.636 139 113 297 295 208 184 278 204 242 222 162 292
2021/20221.700 102 165 121 158 144 195 68 91 70 127 113 346
2022/20233.212 383 842 338 278 213 518 56 164 280 34 65 41
2023/20242.685 97 77 104 115 326 670 465 128 172 67 49 415
2024/20255.133 399 851 610 322 550 277 447 226 793 658 0 0
Totale 23.496